| |||
|
|
>Не большинство, а ровно одно (ВОЗовское). Радуйся, восстановлено уже. Опять врешь же, ну нахуя так делать? https://www.abc.net.au/news/2020-06-0 The Lancet's study caused ripple effects The WHO's decision to halt its trials on hydroxychloroquine as a result of the study had knock-on effects across the medical profession. The United Kingdom's COPCOV trial, which was investigating whether hydroxychloroquine could prevent healthcare workers contracting COVID-19, was put on hold just a week after launch. French company Sanofi also temporarily stopped recruiting for its study into the drug. Both the UK and French studies have yet to resume. However, the UK Recovery Trial only paused briefly before proceeding after making safety checks, and has signed up about 4,500 recruits. Swiss pharmaceutical company Novartis has also continued with its trial. Добавить комментарий: |
||||